Bacteriophage Market Size Estimated to Reach USD 1,441.3 MN By 2028, With 3.5 % CAGR: Statistics Report by Credence Research

 Breaking News
  • No posts were found

Bacteriophage Market Size Estimated to Reach USD 1,441.3 MN By 2028, With 3.5 % CAGR: Statistics Report by Credence Research

July 06
18:32 2022
Bacteriophage Market Size Estimated to Reach USD 1,441.3 MN By 2028, With 3.5 % CAGR: Statistics Report by Credence Research
The key players in the global Bacteriophage Market in terms of value and volume are Eliava Biopreparations Ltd., Pherecydes Pharma, Armata Pharmaceuticals, Inc., Phagelux, Inc., Nextbiotics, InnoPhage, Ltd, Locus Biosciences, Inc., TechnoPhage, Eligo Bioscience SA, Phagomed Biopharma GmbH., PhagePro, Inc., Intralytix, Inc., Adaptive Phage Therapeutics, Enbiotix, Inc., Intodeworld, Inc., BiomX Ltd., Fixed-phage Ltd., Micreos BV, ContraFect Corporation, Phi Therapeutics, and OPTIPHARM Co., Ltd.

The latest market report published by Credence Research, Inc. “Global Bacteriophage Market: Growth, Future Prospects, and Competitive Analysis, 2016 – 2028”. The Global Bacteriophage Market generated revenue of around USD 1,172.5 million in 2021 and is anticipated to grow a CAGR of over 3.5 % during the forecast period from 2022 to 2028 to reach around USD 1,441.3 million in 2028. While cumulative growth opportunity presented by the global Bacteriophage Market is around USD 268.8 million during 2022 to 2028.

The rise in the incidence of various antibiotic-resistant illnesses around the world is expected to help the worldwide bacteriophage market grow. The Bacteriophage market is predicted to increase at a substantial rate due to rising antibiotic resistance infection manufacturing, rising research efforts for therapy development, and rising adoption of growth methods like acquisitions and collaborations by industry participants. Increased government funding to assist phage therapy producers in creating a novel way to reduce antimicrobial-resistant infection cases is expected to promote market growth. Bacteriophages’ growing popularity as an alternative to antibiotics is offering numerous prospects in the bacteriophage market. The increased usage of this medication in the treatment or prevention of bacterial illnesses in individuals is enhancing the worldwide bacteriophage market’s sales potential.

Browse Full Reporthttps://www.credenceresearch.com/report/bacteriophage-market

The global Bacteriophage Market is bifurcated into Product, Route of Administration, Application, Distribution Channel, and Geography. Based on Product, the market is categorized into Phage Probiotics, and Phage Therapeutics. Based on the Route of Administration, the market is categorized into Oral, Topical, and Others. Based on Application, the market is categorized into Gastroenterology, Respiratory Infection Treatment, Skin Infection Treatment, Wound Prophylaxis, Urogenital Infection Treatment, and Others. Based on Distribution Channel, the market is categorized into Retail Pharmacies, Hospital Pharmacies, and Online Pharmacies. Based on geography, the market is segmented as Europe, North America, Asia Pacific, Latin America, and the Middle East and Africa.

Because of the presence of major market players, the bacteriophage therapy market is expected to grow rapidly in the near future. Market participants are increasingly focusing on inorganic growth strategies such as collaborations and partnerships to strengthen their pipeline phage therapy candidates and to improve their research and development capabilities.

In January 2019, Locus Biosciences Inc. announced an exclusive collaboration and licence agreement with Janssen Pharmaceuticals, Inc. (part of Johnson & Johnson’s Janssen Pharmaceutical Companies) to develop, manufacture, and commercialise CRISPR-Cas3-enhanced bacteriophage (crPhage) products targeting two key bacterial pathogens for the treatment of respiratory tract infection and other related infections. Janssen Pharmaceuticals, Inc. received a licence from Locus Biosciences Inc. under this agreement for a CRISPR-Cas3-enhanced bacteriophage product.

Why to Buy This Report-

  • The report provides a qualitative as well as quantitative analysis of the global Bacteriophage Market by segments, current trends, drivers, restraints, opportunities, challenges, and market dynamics with the historical period from 2016-2020, the base year- 2021, and projected period 2022-2028.
  • The report contains information related to the competitive landscape like how the key players in the market are operating at a global, regional, and country-level
  • In-depth analysis of the global market segmentation on the basis of Product, Route of Administration, Application, and Distribution Channel.
  • The global Bacteriophage Market report also includes the analysis of the market at a global, regional, and country-level along with key market trends, major players analysis, market growth strategies, and key application areas.

Browse Full Reporthttps://www.credenceresearch.com/report/bacteriophage-market

Table Of Content:

1. Preface

1.1. Report Description

1.1.1. Purpose of the Report

1.1.2. Target Audience

1.1.3. USP and Key Offerings

1.2. Research Scope

1.3. Research Methodology

1.3.1. Phase I – Secondary Research

1.3.2. Phase II – Primary Research

1.3.3. Phase III – Expert Panel Review

1.3.4. Approach Adopted

1.3.4.1. Top-Down Approach

1.3.4.2. Bottom-Up Approach

1.3.5. Assumptions

1.4. Market Segmentation

2. Executive Summary

2.1. Market Snapshot: Global Bacteriophage Market

3. Market Dynamics & Factors Analysis

3.1. Introduction

3.1.1. Global Bacteriophage Market Value, 2016-2028, (US$ Bn)

3.2. Market Dynamics

3.2.1. Key Growth Trends

3.2.2. Major Industry Challenges

3.2.3. Key Growth Pockets

3.3. Attractive Investment Proposition,2021

3.3.1. Administration

3.3.2. Product

3.3.3. Application

3.3.4. Distribution Channel

3.4. Porter’s Five Forces Analysis

3.4.1. Threat of New Entrants

3.4.2. Bargaining Power of Buyers/Consumers

3.4.3. Bargaining Power of Suppliers

3.4.4. Threat of Substitute Types

3.4.5. Intensity of Competitive Rivalry

3.5. Value Chain Analysis

4. Market Positioning of Key Players, 2021

4.1. Company market share of key players, 2021

4.2. Top 6 Players

4.3. Top 3 Players

4.4. Major Strategies Adopted by Key Players

5. COVID 19 Impact Analysis

5.1. Global Bacteriophage Market Pre Vs Post COVID 19, 2019 – 2028

5.2. Impact on Import & Export

5.3. Impact on Demand & Supply

6. North America

6.1. North America Bacteriophage Market, by Country, 2016-2028(US$ Bn)

6.1.1. U.S.

6.1.2. Canada

6.1.3. Mexico

6.2. North America Bacteriophage Market, by Type, 2016-2028(US$ Bn)

6.2.1. Overview

6.2.2. Phage Probiotics

6.2.3. Phage Therapeutics

6.3. North America Bacteriophage Market, by Administration, 2016-2028(US$ Bn)

6.3.1. Overview

6.3.2. Oral

6.3.3. Topical

6.3.4. Solvents

6.3.5. Others

6.4. North America Bacteriophage Market, by Application, 2016-2028(US$ Bn)

6.4.1. Overview

6.4.2. Gastroenterology

6.4.3. Respiratory Infection Treatment

6.4.4. Skin Infection Treatment

6.4.5. Wound Prophylaxis

6.4.6. Urogenital Infection Treatment

6.4.7. Others

6.5. North America Bacteriophage Market, by Distribution Channel, 2016-2028(US$ Bn)

6.5.1. Overview

6.5.2. Retail Pharmacies

6.5.3. Hospital Pharmacies

6.5.4. Online Pharmacies

6.5.5. Other

Browse Full Reporthttps://www.credenceresearch.com/report/bacteriophage-market

About Us

Credence Research is a worldwide market research and counseling firm that serves driving organizations, governments, nonlegislative associations, and not-for-benefits. We offer our customers some assistance with making enduring enhancements to their execution and understand their most imperative objectives. Over almost a century, we’ve manufactured a firm extraordinarily prepared to this task.

Media Contact
Company Name: Credence Research
Contact Person: Chris Smith
Email: Send Email
Phone: 18003618290
City: SAN JOSE
State: CA
Country: United States
Website: https://www.credenceresearch.com/

Related Articles

Categories